A prominent shareholder at Novartis is advocating for a restructuring of the board after significant setbacks in drug trials ...
Natco Pharma's board has approved raising ₹1300 crore via a rights issue. This funding will bolster their acquisition ...
AstraZeneca's tozorakimab shows promise in reducing flare-ups of chronic obstructive pulmonary disease (COPD) by 29% to 34%, ...
Sun Pharmaceutical Industries Ltd has launched a new wholly-owned subsidiary, Sun Pharma Global Treasury Centre IFSC Ltd, in ...
ChrysCapital is set to acquire a 20-25% stake in Linux Laboratories, a CNS-focused pharmaceutical company in Chennai, for approximately $60-65 million, marking a significant investment in India’s ...
Copenhagen: Novo Nordisk said on Monday that in a late-stage trial, 40.4% of children aged 6 to under 12 treated with semaglutide, the active ingredient in its blockbuster weight-loss drug Wegovy, ...
A new study suggests that Tylenol usage during pregnancy may impact the development of female reproductive organs in ...
ETPharma.com brings latest otsuka pharmaceutical news, views and updates from all top sources for the Indian Pharma industry.
Novartis' cholesterol drug pelacarsen fails to reduce heart attack and stroke risk in late-stage study, impacting investor ...
Sandoz, the Swiss drugmaker, aims to double its annual net sales by 2035, focusing on biosimilars. The company plans to ...
Sun Pharmaceutical Industries has secured investment-grade ratings from Moody's and S&P for its proposed $11.75 billion ...
Biocon has signed a significant 10-year contract to supply pertuzumab, a breast cancer drug, in Brazil, emphasizing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results